Skip to content

Collaborative Care Model on Type 2 Diabetic Patients

The Impact of Collaborative Care Model in the Management of Primary Care Patients With Type 2 Diabetes Mellitus in Singapore

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03553862
Enrollment
255
Registered
2018-06-12
Start date
2018-05-11
Completion date
2020-05-02
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 Diabetes

Brief summary

The purpose of this study is to determine the effectiveness of the collaborative care model in Singapore in which clinical pharmacists, nurses and dietitians are active participants who collaborate with physicians in caring for patients with Type 2 diabetes mellitus (DM).Since DM is a cardiovascular risk equivalent, co-morbidities such as hypertension (HTN) and dyslipidaemia (DLP) will also be evaluated to assess the holistic care provided for the investigator's patients afflicted with these top chronic diseases in Singapore.

Detailed description

Specifically, this study aims to evaluate the effectiveness of an integrated collaborative care model comprising of a healthcare team (physician, clinical pharmacist, nurse, and/or dietitian) compared to the usual or conventional healthcare model (physician-centered care) mainly in the clinical, humanistic and economic outcomes.

Interventions

BEHAVIORALcollaborative care

The intervention arm will receive collaborative care from a team of healthcare professionals that consists of pharmacist, physicians, nurses and dietitians. Patients in the intervention group will also receive clinical interventions carried out by the pharmacist.nurses and dietitians as well as a pharmacist.

Sponsors

National University of Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 21 years with Type 2 DM (HbA1c \> 7%) and polypharmacy (≥ 5 medications) will be eligible for this study.

Exclusion criteria

* Patients with Type 1 DM or who are unable to communicate independently in English, Chinese or Malay will be excluded from this study.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Glycerides (TG) at 12-month12-monthChanges of TG in mg/dL
Change from baseline Body mass index (BMI) at 12 months12-monthChange BMI in kg/m\^2
Change from baseline Glycated Haemoglobin (HbA1c) at 12-month12-monthChanges of HbA1c in %
Change from baseline Systolic Blood Pressure (SBP) at 12-month12-monthChange of SBP in mmHg
Change from baseline Low-density lipoprotein (LDL) at 12-month12-monthChanges of LDL in mg/dL
Change from baseline High-density lipoprotein (HDL) at 12-month12-monthChanges of HDL in mg/dL
Change from baseline Total cholesterol (TC) at 12-month12-monthChanges of TC in mg/dL
Change from baseline Body mass index (BMI) at 6-monthbaseline and 6-monthChange of BMI in kg/m\^2
Change from baseline Glycated Haemoglobin (HbA1c) at 6-monthbaseline and 6-monthChange of HbA1c in %
Changes from baseline Systolic Blood Pressure (SBP) at 6-monthbaseline and 6-monthChange of SBP in mmHg
Change from baseline Low-density lipoprotein (LDL) at 6-monthbaseline and 6-monthChange of LDL in mg/dL
Change from baseline High-density lipoprotein (HDL) at 6-monthbaseline and 6-monthChange of HDL in mg/dL
Change from baseline Total cholesterol (TC) at 6-monthbaseline and 6-monthChange of TC in mg/dL
Change from baseline Glycerides (TG) at 6-monthbaseline and 6-monthChanges of TG in mg/dL
Incidence of hypoglycaemia6-monthIncidence of hypoglycaemia

Secondary

MeasureTime frameDescription
The 5-level EQ-5D version (5Q-5D-5L)baseline5Q-5D-5L is a questionnaire containing 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) with 5 levels (no problems, slight problems, moderate problems, severe problems and extreme problems) for the patients to indicate their health stage.
Audit of Diabetes Dependent Quality of Life (ADDQoL)baselineThe ADDQoL is a 19-item questionnaire measuring the effects of diabetes and its treatment on individuals' quality of life.
Summary of Diabetes Self-Care Activities (SDSCA)baselineThe SDSCA measure is a brief self-report questionnaire of diabetes self-management that includes 14 items assessing the following aspects of the diabetes regimen: general dies, specific diet, exercise, blood-glucose testing, foot care, and smoking.
Self-report Hypoglycaemia QuestionbaselineIt is 5-item questionnaire for the patients with diabetes to self-assess their symptoms of hypoglycaemia.
Work Productivity and Activity Impairment questionnaire, General Health version (WPAI-GH)6-monthThe WPAI-GH is a 6-item questionnaire measuring absenteeism, presenteeism, overall work productivity loss, and daily activity impairment with a 10-point scale that range from 0 (no effect on daily activities) to 10 (serious effect on daily activities).
The Problem Area in Diabetes (PAID)baselineThe PAID is a valid and reliable 20-item questionnaire measuring diabetes-related distress with a five-point Likert scale that ranges from 0 (not a problem) to 4 (serious problem).

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026